DeAnne Stolarik

1.3k total citations
20 papers, 730 citations indexed

About

DeAnne Stolarik is a scholar working on Infectious Diseases, Pharmaceutical Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, DeAnne Stolarik has authored 20 papers receiving a total of 730 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Infectious Diseases, 4 papers in Pharmaceutical Science and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in DeAnne Stolarik's work include Drug Solubulity and Delivery Systems (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). DeAnne Stolarik is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Hepatitis C virus research (4 papers) and HIV/AIDS drug development and treatment (4 papers). DeAnne Stolarik collaborates with scholars based in United States and United Kingdom. DeAnne Stolarik's co-authors include Donald J. Osterling, Gary J. Jenkins, Geoff G. Z. Zhang, Xiaochun Lou, Lynne S. Taylor, Wenqing Gao, Amanda M. Olson, Larry R. Solomon, David Maag and Sanjay C. Panchal and has published in prestigious journals such as Annals of Neurology, Scientific Reports and Journal of Controlled Release.

In The Last Decade

DeAnne Stolarik

20 papers receiving 720 citations

Peers

DeAnne Stolarik
Tae‐Sung Koo South Korea
Elisa Toropainen Finland
Jagdish K. Jaiswal New Zealand
Gemma Quincoces Spain
Lei Peng China
Tracy J Worzella United States
Yaping Han China
Jianyi Wang China
Hoang M. Trinh United States
Ayumi Sato Japan
Tae‐Sung Koo South Korea
DeAnne Stolarik
Citations per year, relative to DeAnne Stolarik DeAnne Stolarik (= 1×) peers Tae‐Sung Koo

Countries citing papers authored by DeAnne Stolarik

Since Specialization
Citations

This map shows the geographic impact of DeAnne Stolarik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by DeAnne Stolarik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites DeAnne Stolarik more than expected).

Fields of papers citing papers by DeAnne Stolarik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by DeAnne Stolarik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by DeAnne Stolarik. The network helps show where DeAnne Stolarik may publish in the future.

Co-authorship network of co-authors of DeAnne Stolarik

This figure shows the co-authorship network connecting the top 25 collaborators of DeAnne Stolarik. A scholar is included among the top collaborators of DeAnne Stolarik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with DeAnne Stolarik. DeAnne Stolarik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yi, Xiaochun Lou, Rodger F. Henry, et al.. (2022). Overcoming Bioavailability Challenges of Dasabuvir and Enabling a Triple-Combination Direct-Acting Antiviral HCV Regimen through a Salt of Very Weak Acid for Oral Delivery. Molecular Pharmaceutics. 19(7). 2367–2379. 5 indexed citations
2.
Rosebraugh, Matthew, Eric A. Voight, Ehab M. Moussa, et al.. (2021). Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease. Annals of Neurology. 90(1). 52–61. 46 indexed citations
3.
Randolph, John T., Tongmei Li, A. Chris Krueger, et al.. (2020). Discovery of 2-aminoisobutyric acid ethyl ester (AIBEE) phosphoramidate prodrugs for delivering nucleoside HCV NS5B polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 30(7). 126986–126986. 3 indexed citations
4.
Lou, Xiaochun, Donald J. Osterling, DeAnne Stolarik, et al.. (2020). Amorphous solid dispersions of enzalutamide and novel polysaccharide derivatives: investigation of relationships between polymer structure and performance. Scientific Reports. 10(1). 18535–18535. 51 indexed citations
5.
Randolph, John T., Eric A. Voight, Stephen N. Greszler, et al.. (2020). Prodrug Strategies to Improve the Solubility of the HCV NS5A Inhibitor Pibrentasvir (ABT-530). Journal of Medicinal Chemistry. 63(19). 11034–11044. 11 indexed citations
6.
Purohit, Hitesh S., Niraj S. Trasi, Donald J. Osterling, et al.. (2019). Assessing the Impact of Endogenously Derived Crystalline Drug on the in Vivo Performance of Amorphous Formulations. Molecular Pharmaceutics. 16(8). 3617–3625. 27 indexed citations
7.
Lou, Xiaochun, Donald J. Osterling, DeAnne Stolarik, et al.. (2018). Relationship between amorphous solid dispersion in vivo absorption and in vitro dissolution: phase behavior during dissolution, speciation, and membrane mass transport. Journal of Controlled Release. 292. 172–182. 142 indexed citations
8.
Cassar, Steven, Amanda M. Olson, Xin Huang, et al.. (2017). Measuring drug absorption improves interpretation of behavioral responses in a larval zebrafish locomotor assay for predicting seizure liability. Journal of Pharmacological and Toxicological Methods. 88(Pt 1). 56–63. 24 indexed citations
9.
Cassar, Steven, Amanda M. Olson, Wayne R. Buck, et al.. (2017). From the Cover: Inhibitors of Nicotinamide Phosphoribosyltransferase Cause Retinal Damage in Larval Zebrafish. Toxicological Sciences. 161(2). 300–309. 17 indexed citations
10.
Randolph, John T., Charles A. Flentge, Todd W. Rockway, et al.. (2016). Discovery of fluorobenzimidazole HCV NS5A inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(22). 5462–5467. 4 indexed citations
11.
Hopkins, Todd A., Yan Shi, Luis E. Rodrı́guez, et al.. (2015). Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP Inhibitors. Molecular Cancer Research. 13(11). 1465–1477. 198 indexed citations
12.
Nunamaker, Elizabeth A., et al.. (2014). Clinical efficacy of sustained-release buprenorphine with meloxicam for postoperative analgesia in beagle dogs undergoing ovariohysterectomy.. PubMed. 53(5). 494–501. 34 indexed citations
13.
García, Kelly, et al.. (2014). Pharmacokinetics of sustained-release and transdermal buprenorphine in Göttingen minipigs (Sus scrofa domestica).. PubMed. 53(6). 692–9. 27 indexed citations
14.
Hopkins, Todd A., Larry R. Solomon, Yang Shi, et al.. (2014). 246 PARP inhibitors trap PARP1 onto damaged DNA via catalytic inhibition and not by an allosteric mechanism. European Journal of Cancer. 50. 82–83. 4 indexed citations
15.
Consigny, P. Macke, et al.. (2013). Chemical Renal Denervation in the Rat. CardioVascular and Interventional Radiology. 37(1). 218–223. 11 indexed citations
16.
Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Synthesis and biological evaluation of heterocycle containing adamantane 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(20). 5414–5419. 18 indexed citations
17.
Sorensen, Bryan K., Jiahong Wang, Steven Fung, et al.. (2006). Adamantane 11-β-HSD-1 inhibitors: Application of an isocyanide multicomponent reaction. Bioorganic & Medicinal Chemistry Letters. 16(23). 5958–5962. 30 indexed citations
18.
Yeh, Vince S. C., Ravi Kurukulasuriya, Steven Fung, et al.. (2006). Discovery of orally active butyrolactam 11β-HSD1 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(21). 5555–5560. 13 indexed citations
19.
Witte, David G., Michael E. Brune, Ivan Milicic, et al.. (2002). Modeling of Relationships between Pharmacokinetics and Blockade of Agonist-Induced Elevation of Intraurethral Pressure and Mean Arterial Pressure in Conscious Dogs Treated with α1-Adrenoceptor Antagonists. Journal of Pharmacology and Experimental Therapeutics. 300(2). 495–504. 16 indexed citations
20.
Sciotti, Richard J., Marina Pliushchev, Paul E. Wiedeman, et al.. (2002). The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class. Bioorganic & Medicinal Chemistry Letters. 12(16). 2121–2123. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tae‐Sung Koo Breakdown of academic impact, for papers by Elisa Toropainen Breakdown of academic impact, for papers by Jagdish K. Jaiswal Breakdown of academic impact, for papers by Gemma Quincoces Breakdown of academic impact, for papers by Lei Peng Breakdown of academic impact, for papers by Tracy J Worzella Breakdown of academic impact, for papers by Yaping Han Breakdown of academic impact, for papers by Jianyi Wang Breakdown of academic impact, for papers by Hoang M. Trinh Breakdown of academic impact, for papers by Ayumi Sato
Rankless by CCL
2026